Fluoroquinolone Prophylaxis Against Febrile Neutropenia in Areas With High Fluoroquinolone Resistance—An Asian Perspective
Febrile neutropenia remains a major cause of morbidity and mortality in patients receiving chemotherapy. Major prophylactic strategies include granulocyte colony-stimulating factor and antibiotics, the most widely used of which are fluoroquinolones. While fluoroquinolone prophylaxis has been shown t...
Main Authors: | Esther Shu-Ting Ng, Yixin Liew, Liang Piu Koh, Li Yang Hsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-09-01
|
Series: | Journal of the Formosan Medical Association |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664610601027 |
Similar Items
-
Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
by: Chong Y, et al.
Published: (2017-06-01) -
Voriconazole in Prevention and Treatment of Febrile Neutropenia
by: Hamidreza Taghva Masoumi, et al.
Published: (2018-02-01) -
Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
by: Nageswara Reddy Palukuri, et al.
Published: (2020-01-01) -
How I treat febrile neutropenia
by: Marcio Nucci
Published: (2021-02-01) -
Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
by: Doaa Naeem, et al.
Published: (2018-08-01)